Whole Genome Diagnostics
Approximately $5 trillion is spent annually on global health care. Noteworthy is that 65% of therapy decisions are based on the results of diagnostic tests and that molecular diagnostics is the fastest-growing segment of this diagnostics market.

Major diagnostic advances enabled by whole-genome sequencing immediately supported by GQ-Dx include consolidation of existing molecular tests, extensive pharmacogenomic screening, and a new generation of discoveries in the diagnosis of complex, multi-gene disorders.

Report Mockup